Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
233 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (2)
  • Currently Recruiting (1)
  • (-) Closed (1)

Medical Condition

  • Show all (14)
  • Addiction (14)
    • (-) Alcohol (1)
    • Cocaine (2)
    • Marijuana (2)
    • Nicotine (2)
    • Opioids (6)
Displaying 1 - 1 of 1

Study to Evaluate the Efficacy & Safety of Treatment with Efimosfermin Alfa in Adult Participants with Alcohol-related Liver Disease (ALD)

Condition: Addiction / Alcohol
Investigator: Gene Im, MD, FAASLD
Status: Closed
Researchers at Columbia University Irving Medical Center are investigating whether the investigational medication efimosfermin is safe and effective in improving outcomes for adults with Alcohol-related Liver Disease (ALD). ALD refers to liver damage caused by heavy alcohol consumption. The study uses a placebo for comparison because there are no approved…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science